Central Indiana Cancer Centers is a clinical research site located in Fishers, Indiana, United States 46227.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Central Indiana Cancer Centers has participated in 8 clinical trials.
Therapeutic areas: Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL), Breast Cancer, Melanoma.
Sponsors: Millennium Pharmaceuticals, Inc., NSABP Foundation Inc, Bristol-Myers Squibb.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Central Indiana Cancer Centers has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Central Indiana Cancer Centers has 8 clinical trials on record. Their work covers Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL), Breast Cancer, Melanoma.
Yes — Central Indiana Cancer Centers holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.